vs
Axil Brands, Inc.（AXIL）与Arcus Biosciences, Inc.（RCUS）财务数据对比。点击上方公司名可切换其他公司
Arcus Biosciences, Inc.的季度营收约是Axil Brands, Inc.的1.4倍（$11.0M vs $8.1M），Axil Brands, Inc.净利率更高（8.7% vs -963.6%，领先972.3%），Axil Brands, Inc.同比增速更快（5.2% vs -52.2%），Axil Brands, Inc.自由现金流更多（$906.4K vs $-121.0M），过去两年Axil Brands, Inc.的营收复合增速更高（12.1% vs 4.9%）
Axil Brands是一家总部位于美国的专业消费电子企业，主营高端听力防护设备、音频增强装置及个性化音频配件，旗下产品涵盖定制耳塞、运动蓝牙耳机等，面向全球普通消费者及专业作业群体销售。
Arcus Biosciences是一家处于临床阶段的美国基因编辑上市企业，总部位于北卡罗来纳州达勒姆，成立于2006年。公司依托其专有的“ARCUS”基因组编辑平台，专注于开发体内及体外基因编辑疗法，为相关疾病治疗提供创新解决方案。
AXIL vs RCUS — 直观对比
营收规模更大
RCUS
是对方的1.4倍
$8.1M
营收增速更快
AXIL
高出57.4%
-52.2%
净利率更高
AXIL
高出972.3%
-963.6%
自由现金流更多
AXIL
多$121.9M
$-121.0M
两年增速更快
AXIL
近两年复合增速
4.9%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.1M | $11.0M |
| 净利润 | $704.9K | $-106.0M |
| 毛利率 | 68.1% | — |
| 营业利润率 | 11.1% | -1036.4% |
| 净利率 | 8.7% | -963.6% |
| 营收同比 | 5.2% | -52.2% |
| 净利润同比 | 11.2% | -12.8% |
| 每股收益（稀释后） | $0.09 | $-0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXILRCUS
| Q4 25 | $8.1M | $11.0M | ||
| Q3 25 | $6.9M | $6.0M | ||
| Q2 25 | $5.8M | $8.0M | ||
| Q1 25 | $6.9M | $8.0M | ||
| Q4 24 | $7.7M | $23.0M | ||
| Q3 24 | $5.9M | $7.0M | ||
| Q2 24 | $6.5M | $11.0M | ||
| Q1 24 | $6.5M | $10.0M |
净利润AXILRCUS
| Q4 25 | $704.9K | $-106.0M | ||
| Q3 25 | $334.3K | $-135.0M | ||
| Q2 25 | $-245.6K | $0 | ||
| Q1 25 | $576.7K | $-112.0M | ||
| Q4 24 | $633.7K | $-94.0M | ||
| Q3 24 | $-109.8K | $-92.0M | ||
| Q2 24 | $49.5K | $-93.0M | ||
| Q1 24 | $781.1K | $-4.0M |
毛利率AXILRCUS
| Q4 25 | 68.1% | — | ||
| Q3 25 | 67.6% | — | ||
| Q2 25 | 70.0% | — | ||
| Q1 25 | 71.7% | — | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 71.0% | — | ||
| Q2 24 | 71.5% | — | ||
| Q1 24 | 71.5% | — |
营业利润率AXILRCUS
| Q4 25 | 11.1% | -1036.4% | ||
| Q3 25 | 6.0% | -2366.7% | ||
| Q2 25 | 0.8% | -100.0% | ||
| Q1 25 | 8.4% | -1525.0% | ||
| Q4 24 | 8.7% | -447.8% | ||
| Q3 24 | -2.4% | -1500.0% | ||
| Q2 24 | 2.6% | -963.6% | ||
| Q1 24 | -1.6% | -160.0% |
净利率AXILRCUS
| Q4 25 | 8.7% | -963.6% | ||
| Q3 25 | 4.9% | -2250.0% | ||
| Q2 25 | -4.3% | — | ||
| Q1 25 | 8.3% | -1400.0% | ||
| Q4 24 | 8.2% | -408.7% | ||
| Q3 24 | -1.9% | -1314.3% | ||
| Q2 24 | 0.8% | -845.5% | ||
| Q1 24 | 12.1% | -40.0% |
每股收益（稀释后）AXILRCUS
| Q4 25 | $0.09 | $-0.88 | ||
| Q3 25 | $0.04 | $-1.27 | ||
| Q2 25 | $-0.03 | $0.00 | ||
| Q1 25 | $0.07 | $-1.14 | ||
| Q4 24 | $0.08 | $-1.07 | ||
| Q3 24 | $-0.02 | $-1.00 | ||
| Q2 24 | $0.11 | $-1.02 | ||
| Q1 24 | $0.04 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.0M | $222.0M |
| 总债务越低越好 | $138.3K | $99.0M |
| 股东权益账面价值 | $11.1M | $631.0M |
| 总资产 | $16.2M | $1.1B |
| 负债/权益比越低杠杆越低 | 0.01× | 0.16× |
8季度趋势，按日历期对齐
现金及短期投资AXILRCUS
| Q4 25 | $5.0M | $222.0M | ||
| Q3 25 | $4.1M | $238.0M | ||
| Q2 25 | $4.8M | $248.0M | ||
| Q1 25 | $4.7M | $192.0M | ||
| Q4 24 | $5.2M | $150.0M | ||
| Q3 24 | $4.1M | $201.0M | ||
| Q2 24 | $3.3M | $156.0M | ||
| Q1 24 | $4.9M | $185.0M |
总债务AXILRCUS
| Q4 25 | $138.3K | $99.0M | ||
| Q3 25 | $139.2K | $98.0M | ||
| Q2 25 | $140.2K | $97.0M | ||
| Q1 25 | $141.0K | $48.0M | ||
| Q4 24 | $143.3K | $48.0M | ||
| Q3 24 | $144.3K | $47.0M | ||
| Q2 24 | $146.6K | — | ||
| Q1 24 | — | — |
股东权益AXILRCUS
| Q4 25 | $11.1M | $631.0M | ||
| Q3 25 | $10.2M | $436.0M | ||
| Q2 25 | $9.7M | $549.0M | ||
| Q1 25 | $9.7M | $531.0M | ||
| Q4 24 | $8.8M | $485.0M | ||
| Q3 24 | $7.9M | $565.0M | ||
| Q2 24 | $7.7M | $635.0M | ||
| Q1 24 | $8.8M | $707.0M |
总资产AXILRCUS
| Q4 25 | $16.2M | $1.1B | ||
| Q3 25 | $15.4M | $974.0M | ||
| Q2 25 | $12.9M | $1.1B | ||
| Q1 25 | $13.0M | $1.2B | ||
| Q4 24 | $13.7M | $1.1B | ||
| Q3 24 | $11.4M | $1.3B | ||
| Q2 24 | $11.0M | $1.2B | ||
| Q1 24 | $12.7M | $1.3B |
负债/权益比AXILRCUS
| Q4 25 | 0.01× | 0.16× | ||
| Q3 25 | 0.01× | 0.22× | ||
| Q2 25 | 0.01× | 0.18× | ||
| Q1 25 | 0.01× | 0.09× | ||
| Q4 24 | 0.02× | 0.10× | ||
| Q3 24 | 0.02× | 0.08× | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $934.8K | $-120.0M |
| 自由现金流经营现金流 - 资本支出 | $906.4K | $-121.0M |
| 自由现金流率自由现金流/营收 | 11.1% | -1100.0% |
| 资本支出强度资本支出/营收 | 0.3% | 9.1% |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXILRCUS
| Q4 25 | $934.8K | $-120.0M | ||
| Q3 25 | $-739.2K | $-97.0M | ||
| Q2 25 | $194.4K | $-133.0M | ||
| Q1 25 | $-169.9K | $-132.0M | ||
| Q4 24 | $1.0M | $-100.0M | ||
| Q3 24 | $897.3K | $26.0M | ||
| Q2 24 | $-336.6K | $-94.0M | ||
| Q1 24 | $-912.8K | $-2.0M |
自由现金流AXILRCUS
| Q4 25 | $906.4K | $-121.0M | ||
| Q3 25 | $-747.6K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-258.2K | $-133.0M | ||
| Q4 24 | $941.1K | $-101.0M | ||
| Q3 24 | — | $25.0M | ||
| Q2 24 | $-394.9K | — | ||
| Q1 24 | $-922.1K | $-6.0M |
自由现金流率AXILRCUS
| Q4 25 | 11.1% | -1100.0% | ||
| Q3 25 | -10.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -3.7% | -1662.5% | ||
| Q4 24 | 12.2% | -439.1% | ||
| Q3 24 | — | 357.1% | ||
| Q2 24 | -6.1% | — | ||
| Q1 24 | -14.3% | -60.0% |
资本支出强度AXILRCUS
| Q4 25 | 0.3% | 9.1% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 1.3% | 12.5% | ||
| Q4 24 | 0.9% | 4.3% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 0.1% | 40.0% |
现金转化率AXILRCUS
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
RCUS
| Other | $5.0M | 45% |
| Other Collaboration Revenue | $4.0M | 36% |
| Access Rights And Option Continuation Periods | $2.0M | 18% |
